Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

Cholesterol-lowering drug slows progression of eye disease in people with diabetes

Evidence

The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%. The results were announced today at the American Diabetes Association Scientific Sessions and published in NEJM Evidence.

Document this CPD Copy URL Button

Google

Google Keep

LinkedIn Share Share on Linkedin

Estimated reading time: 1 minute(s)

Latest: Psychiatryai.com #RAISR4D Evidence

Cool Evidence: Engaging Young People and Students in Real-World Evidence

Real-Time Evidence Search [Psychiatry]

AI Research

Cholesterol-lowering drug slows progression of eye disease in people with diabetes

Copy WordPress Title

🌐 90 Days

Evidence Blueprint

Cholesterol-lowering drug slows progression of eye disease in people with diabetes

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

More Evidence

Cholesterol-lowering drug slows progression of eye disease in people with diabetes

🌐 365 Days

Floating Tab
close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI RAISR 4D System Psychiatry + Mental Health